Table 12.26 Effectiveness of Intrathecal Baclofen for Spasticity in Children post ABI
by Camila | Dec 12, 2018
Table 12.26 Effectiveness of Intrathecal Baclofen for Spasticity in Children post ABI
Author/ Year/ Country/ Study Design/ N |
Methods |
Outcome |
Walter et al. (2015)
Switzerland
Case Series
N=3 |
Population: ABI: Hypoxia=3; Mean Age=4.0 yr; Gender: Male=2, Female=1; Mean Time Post Injury=64.3 days.
Treatment: Patients received intrathecal baclofen pump implants and were monitored for a mean of 2315 day (approximately 6.3 yr). Dosage increased from 117 mcg at baseline to 660mcg at the study end. Assessments were conducted at baseline and annually for at least 5 yr.
Outcome Measure: Modified Ashworth Scale (MAS), complication rate. |
- Spasticity on MAS decreased from baseline to post-treatment in the upper and lower extremities.
- Five occurrences of pump-related complications were observed including two cases of skin protrusion, one case of infection, one case of lumbar cerebrospinal fluid leak, and one case of intractable spasticity requiring a pump replacement.
|
PEDro=Physiotherapy Evidence Database rating scale score (
Moseley et al., 2002).